S'abonner

The microbiome in allergic disease: Current understanding and future opportunities—2017 PRACTALL document of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology - 19/04/17

Doi : 10.1016/j.jaci.2017.02.007 
Yvonne J. Huang, MD a, Benjamin J. Marsland, PhD b, Supinda Bunyavanich, MD, MPH, MPhil c, Liam O'Mahony, PhD d, Donald Y.M. Leung, MD, PhD e, Antonella Muraro, MD, PhD f, Thomas A. Fleisher, MD g,
a Division of Pulmonary and Critical Care, Department of Internal Medicine, University of Michigan, Ann Arbor, Mich 
b Service de Pneumologie, Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland 
c Division of Allergy and Immunology, Departments of Pediatrics and Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY 
d Molecular Immunology, Swiss Institute of Allergy and Asthma Research, University of Zurich, Davos, Switzerland 
e Division of Allergy and Immunology, Department of Pediatrics, National Jewish Health, Denver, Colo 
f Food Allergy Referral Centre Veneto Region, Department of Women and Child Health, Padua General University Hospital, Padua, Italy 
g Department of Laboratory Medicine, Clinical Center, National Institutes of Health, Bethesda, Md 

Corresponding author: Thomas A. Fleisher, MD, Department of Laboratory Medicine, CC, National Institutes of Health, 10 Center Dr, MSC 1508, Bethesda, MD 20892-1508.Department of Laboratory MedicineCC, National Institutes of Health10 Center Dr, MSC 1508BethesdaMD20892-1508

Abstract

PRACTALL is a joint initiative of the American Academy of Allergy, Asthma & Immunology and the European Academy of Allergy and Clinical Immunology to provide shared evidence-based recommendations on cutting-edge topics in the field of allergy and immunology. PRACTALL 2017 is focused on what has been established regarding the role of the microbiome in patients with asthma, atopic dermatitis, and food allergy. This is complemented by outlining important knowledge gaps regarding its role in allergic disease and delineating strategies necessary to fill these gaps. In addition, a review of progress in approaches used to manipulate the microbiome will be addressed, identifying what has and has not worked to serve as a baseline for future directions to intervene in allergic disease development, progression, or both.

Le texte complet de cet article est disponible en PDF.

Key words : Microbiome, microbiota, dysbiosis, asthma, atopic dermatitis, food allergy, systems biology, probiotic, prebiotic

Abbreviations used : AD, EH, SCFA


Plan


 Supported in part by the National Institutes of Health (NIH) Intramural Program of the NIH Clinical Center.
 Disclosure of potential conflict of interest: Y. J. Huang has received travel support and payment for lectures from the American Academy of Allergy, Asthma & Immunology and has received travel support from the National Academy of Science, Engineering, and Medicine; the National Institutes of Health (NIH), the American College of Chest Physicians, the European Respiratory Society, and the Massachusetts Institute of Technology. S. Bunyavanich has received a grant from the NIH/National Institute of Allergy and Infectious Diseases. L. O'Mahony has consultant arrangements with Alimentary Health Ltd and has received grants from GlaxoSmithKline. D. Y. M. Leung has received a grant from MedImmune; has received consulting fees or honoraria from Novartis, Regeneron, and Sanofi-Aventis; and has received payment for writing or reviewing this manuscript from Omnia-Prova Education Collaborative. A. Muraro has consultant arrangements with Meda, Novartis, and Menarini; is employed by Padua University Hospital; and has received payment for lectures from Meda and Menarini. T. A. Fleisher is President of the American Academy of Allergy, Asthma & Immunology; has received payment for lectures from the Boston City Wide Allergy Meeting, the Louisiana Society of Allergy, Asthma, and Immunology, and the Alaska Society of Allergy, Asthma, and Immunology; and has received royalties as coeditor of Clinical Immunology: Principles and Practice. B. J. Marsland declares that he has no relevant conflicts of interest.


© 2017  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 139 - N° 4

P. 1099-1110 - avril 2017 Retour au numéro
Article précédent Article précédent
  • Functional relevance of microbiome signatures: The correlation era requires tools for consolidation
  • Ludovica F. Buttó, Dirk Haller
| Article suivant Article suivant
  • International consensus guidelines for the diagnosis and management of food protein–induced enterocolitis syndrome: Executive summary—Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & Immunology
  • Anna Nowak-W?grzyn, Mirna Chehade, Marion E. Groetch, Jonathan M. Spergel, Robert A. Wood, Katrina Allen, Dan Atkins, Sami Bahna, Ashis V. Barad, Cecilia Berin, Terri Brown Whitehorn, A. Wesley Burks, Jean-Christoph Caubet, Antonella Cianferoni, Marisa Conte, Carla Davis, Alessandro Fiocchi, Kate Grimshaw, Ruchi Gupta, Brittany Hofmeister, J.B. Hwang, Yitzhak Katz, George N. Konstantinou, Stephanie A. Leonard, Jennifer Lightdale, Sean McGhee, Sami Mehr, Stefano Miceli Sopo, Giovanno Monti, Antonella Muraro, Stacey Katherine Noel, Ichiro Nomura, Sally Noone, Hugh A. Sampson, Fallon Schultz, Scott H. Sicherer, Cecilia C. Thompson, Paul J. Turner, Carina Venter, A. Amity Westcott-Chavez, Matthew Greenhawt

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.